Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Revenues $ 0 $ 0 $ 0 $ 390
Operating expenses:        
Research and development (related party of $153, $124, $306 and $219) 585 656 1,137 1,833
Research and development - effect of Settlement Agreement (Note 6) 0 0 (1,041) 0
General and administrative 1,051 1,039 1,999 2,062
General and administrative - effect of Settlement Agreement (Note 6) 0 0 (700) 0
Total operating expenses 1,636 1,695 1,395 3,895
Operating loss (1,636) (1,695) (1,395) (3,505)
Other income (expense):        
Interest income 2 2 4 6
Interest expense 0 (17) 0 (33)
Interest expense - effect of Settlement Agreement (Note 6) 0 0 122 0
Royalty income 10 4 25 15
Other income 0 0 0 0
Loss on disposal of fixed assets (1) 0 (1) 0
Change in fair value of warrant derivative liability 0 635 0 394
Total other income 11 624 150 382
Net loss $ (1,625) $ (1,071) $ (1,245) $ (3,123)
Loss per common share - basic and diluted (in dollars per share) $ (0.03) $ (0.02) $ (0.02) $ (0.07)
Weighted-average common shares outstanding - basic and diluted (in shares) 63,984 47,767 60,338 47,767